Digital Medicine Platform for Treatment of Cognitive Disorder

Digital Medicine Platform for Treatment of Cognitive Disorder

Akili, a pioneer in therapeutic prescription digital medicine has closed successfully it’s $55 million financing Series C trial of medicine. This funding follows a successful trial, including study, developing and testing a novel digital medicine named AKL- T01. This flagship product of Akili aimed to treat a type of cognitive disorder- attention deficit/hyperactivity disorder (ADHD). Once approved and launched commercially, it would be the first digital and standalone therapeutic medicine for ADHD. Company’s other product in the pipeline and research, AKL-T02 will treat autism spectral disorder (ASD) or what simply known as autism.

Autism refers to another type of cognitive disorder, particularly in children, making them difficult to interact socially. The repetitive behavior and underdeveloped speech and verbal communication render them vulnerable in society. The reason behind autism could be genetic as well as environmental influence.

The above news has brought in a new ray of hope for an autism patient where there is no specific traditional medicine is available for its cure. This new development has the potential for treating this disorder, probably with more efficiency.

This funding will also help to advance products in the pipeline for treating multi sclerosis (MS) and depression. After approval by the U.S. Food and Drug Administration (FDA), it will be launched commercially for the patients. According to Akili AKL-T01 would be a standalone treatment for ADHD.

The company’s founder and CEO Eddie Martucci is quite happy with the response of investors and welcomed the financing. He said this financing indicates faith of people in his company’s potential in digital medicines and growth. According to him, the company will continue to grow and supply novel solutions in the redefined healthcare sector.

Akini Interactive is a company who believes in transforming healthcare through its digital therapeutics medicine solving Neuro-cognitive disorders. It believes in targeting specific cognitive area or nerve which has been suppressed by the dysfunction. The treatment includes, interestingly, not any pill, but customized action video games for patients to play.

Video games are designed by neuroscientists and entertainer engineered with algorithms to treat a cognitive disorder like depression. According to the company, highly-interactive and highly engaging games provide a therapeutic experience to patients which actually benefit them. Through high-end therapeutics interactive video games, the specific regions of the brain could become functional which has been suppressed by the disorder, improving the condition of the patient. There would second by second tracking of patient’s cognitive response and data available for any improvement in the patient’s condition.

AKL- T01 if approved by the FDA and then it would certainly indicate towards the acceptance of new healthcare solutions for patients. It has the capability to transform the whole healthcare process and system in coming years. This funding will boost the confidence of other investors, which are planning to invest or come together for such digital medicine research and development in the future and those patients who are searching for new areas to treat disorders like autism could be more than happy to read such positive news.



Source by Shalini Madhav

Our Gallery

Our Blog

View All

Fun Learning Apps for Children With Autism

  • By : Staff
  • August 7, 2019

Neuro-typical children who grow up naturally with no impediments to their learning and intellectual abilities, are social and can communicate their demands to others. But…

Autism and Its Treatments

  • By : Staff
  • July 24, 2019

What is Autism?Autism is a disability that causes developmental delays in areas such as talk, play, and being socially active. The severity of the symptoms…

Online Education: Suits All Types Of Learning

  • By : Staff
  • May 1, 2019

For thousands of years, people take education as a treasure. We study to prepare ourselves to the responsibilities we should take in the future. To…

Let Us Explore National Employability Enhancement Mission NEEM Scheme

  • By : Staff
  • April 17, 2019

National Employability Enhancement Mission abbreviated as "NEEM" is a scheme in which degree holder youths are trained to be skill full as per industry requirements,…

Understanding Autism – How Children With Autism Use Their Psychic Abilities – A Clairvoyant’s View

  • By : Staff
  • April 3, 2019

Most autistic children I have observed were smart and knew what was going on. They usually had normal intelligence. Besides that, the children with  autism …

Digital Medicine Platform for Treatment of Cognitive Disorder

  • By : Staff
  • March 6, 2019

Akili, a pioneer in therapeutic prescription digital medicine has closed successfully it's $55 million financing Series C trial of medicine. This funding follows a successful…

The Benefits of Animal Therapy For Autism

  • By : Staff
  • December 26, 2018

For those of us who have had pets in our lives, it's no great surprise to learn that interactions with animals can have therapeutic and…

Autism Therapies – Effective Ways Of Treating Individuals With Autism

  • By : Staff
  • December 12, 2018

It might come as a major shock to parents to find their child being diagnosed with  Autism   Spectrum  Disorder (ASD). Most of the times, they…

The Evolution of Autism

  • By : Staff
  • November 28, 2018

What is Autism? Autism is a developmental disorder that begins early in childhood; it is usually noticed in children by age 3. Defining characteristics of…

The Benefits of Vocational Training for the Disabled

  • By : Staff
  • November 14, 2018

Disabilities come in a wide range of conditions and disorders. One might be born physically disabled, while being perfectly mentally capable of working and functioning…

RSS
Follow by Email
Facebook
Facebook